C150H162Br3Cl9F3N21O11 — CID 159437567
3-bromo-N-[(6-chloro-1-propylbenzimidazol-2-yl)methyl]-N-(2-methoxyethyl)benzamide;3-bromo-N-[(7-chloro-1-propylbenzimidazol-2-yl)methyl]-N-methylbenzamide;3-bromo-N-[(7-chloro-1-propylbenzimidazol-2-yl)methyl]-N-propylbenzamide;5-chloro-N-[(7-chloro-1-propylbenzimidazol-2-yl)methyl]-2-methoxy-N-propylbenzamide;5-chloro-N-[[1-(cyclopropylmethyl)benzimidazol-2-yl]methyl]-2-methoxy-N-propylbenzamide;N-[[1-(cyclopropylmethyl)benzimidazol-2-yl]methyl]-N-propyl-3-(trifluoromethyl)benzamide;2,5-dichloro-N-[(6-chloro-1-propylbenzimidazol-2-yl)methyl]-N-(2-methoxyethyl)benzamide (PubChem CID 159437567) has the molecular formula C150H162Br3Cl9F3N21O11 and a molecular weight of 3050.86 g/mol. Its IUPAC name is 3-bromo-N-[(6-chloro-1-propylbenzimidazol-2-yl)methyl]-N-(2-methoxyethyl)benzamide;3-bromo-N-[(7-chloro-1-propylbenzimidazol-2-yl)methyl]-N-methylbenzamide;3-bromo-N-[(7-chloro-1-propylbenzimidazol-2-yl)methyl]-N-propylbenzamide;5-chloro-N-[(7-chloro-1-propylbenzimidazol-2-yl)methyl]-2-methoxy-N-propylbenzamide;5-chloro-N-[[1-(cyclopropylmethyl)benzimidazol-2-yl]methyl]-2-methoxy-N-propylbenzamide;N-[[1-(cyclopropylmethyl)benzimidazol-2-yl]methyl]-N-propyl-3-(trifluoromethyl)benzamide;2,5-dichloro-N-[(6-chloro-1-propylbenzimidazol-2-yl)methyl]-N-(2-methoxyethyl)benzamide.
| Compound Name | 3-bromo-N-[(6-chloro-1-propylbenzimidazol-2-yl)methyl]-N-(2-methoxyethyl)benzamide;3-bromo-N-[(7-chloro-1-propylbenzimidazol-2-yl)methyl]-N-methylbenzamide;3-bromo-N-[(7-chloro-1-propylbenzimidazol-2-yl)methyl]-N-propylbenzamide;5-chloro-N-[(7-chloro-1-propylbenzimidazol-2-yl)methyl]-2-methoxy-N-propylbenzamide;5-chloro-N-[[1-(cyclopropylmethyl)benzimidazol-2-yl]methyl]-2-methoxy-N-propylbenzamide;N-[[1-(cyclopropylmethyl)benzimidazol-2-yl]methyl]-N-propyl-3-(trifluoromethyl)benzamide;2,5-dichloro-N-[(6-chloro-1-propylbenzimidazol-2-yl)methyl]-N-(2-methoxyethyl)benzamide |
|---|---|
| PubChem CID | 159437567 |
| Molecular Formula | C150H162Br3Cl9F3N21O11 |
| Molecular Weight | 3050.86 g/mol |
| Exact Mass | 3041.75 |
| IUPAC Name | 3-bromo-N-[(6-chloro-1-propylbenzimidazol-2-yl)methyl]-N-(2-methoxyethyl)benzamide;3-bromo-N-[(7-chloro-1-propylbenzimidazol-2-yl)methyl]-N-methylbenzamide;3-bromo-N-[(7-chloro-1-propylbenzimidazol-2-yl)methyl]-N-propylbenzamide;5-chloro-N-[(7-chloro-1-propylbenzimidazol-2-yl)methyl]-2-methoxy-N-propylbenzamide;5-chloro-N-[[1-(cyclopropylmethyl)benzimidazol-2-yl]methyl]-2-methoxy-N-propylbenzamide;N-[[1-(cyclopropylmethyl)benzimidazol-2-yl]methyl]-N-propyl-3-(trifluoromethyl)benzamide;2,5-dichloro-N-[(6-chloro-1-propylbenzimidazol-2-yl)methyl]-N-(2-methoxyethyl)benzamide |
| SMILES | CCCN(Cc1nc2cccc(Cl)c2n1CCC)C(=O)c1cc(Cl)ccc1OC.CCCN(Cc1nc2cccc(Cl)c2n1CCC)C(=O)c1cccc(Br)c1.CCCN(Cc1nc2ccccc2n1CC1CC1)C(=O)c1cc(Cl)ccc1OC.CCCN(Cc1nc2ccccc2n1CC1CC1)C(=O)c1cccc(C(F)(F)F)c1.CCCn1c(CN(C)C(=O)c2cccc(Br)c2)nc2cccc(Cl)c21.CCCn1c(CN(CCOC)C(=O)c2cc(Cl)ccc2Cl)nc2ccc(Cl)cc21.CCCn1c(CN(CCOC)C(=O)c2cccc(Br)c2)nc2ccc(Cl)cc21 |
| InChI | InChI=1S/C23H26ClN3O2.C23H24F3N3O.C22H25Cl2N3O2.C21H23BrClN3O2.C21H23BrClN3O.C21H22Cl3N3O2.C19H19BrClN3O/c1-3-12-26(23(28)18-13-17(24)10-11-21(18)29-2)15-22-25-19-6-4-5-7-20(19)27(22)14-16-8-9-16;1-2-12-28(22(30)17-6-5-7-18(13-17)23(24,25)26)15-21-27-19-8-3-4-9-20(19)29(21)14-16-10-11-16;1-4-11-26(22(28)16-13-15(23)9-10-19(16)29-3)14-20-25-18-8-6-7-17(24)21(18)27(20)12-5-2;1-3-9-26-19-13-17(23)7-8-18(19)24-20(26)14-25(10-11-28-2)21(27)15-5-4-6-16(22)12-15;1-3-11-25(21(27)15-7-5-8-16(22)13-15)14-19-24-18-10-6-9-17(23)20(18)26(19)12-4-2;1-3-8-27-19-12-15(23)5-7-18(19)25-20(27)13-26(9-10-29-2)21(28)16-11-14(22)4-6-17(16)24;1-3-10-24-17(22-16-9-5-8-15(21)18(16)24)12-23(2)19(25)13-6-4-7-14(20)11-13/h4-7,10-11,13,16H,3,8-9,12,14-15H2,1-2H3;3-9,13,16H,2,10-12,14-15H2,1H3;6-10,13H,4-5,11-12,14H2,1-3H3;4-8,12-13H,3,9-11,14H2,1-2H3;5-10,13H,3-4,11-12,14H2,1-2H3;4-7,11-12H,3,8-10,13H2,1-2H3;4-9,11H,3,10,12H2,1-2H3 |
| InChIKey | LRTPNCDLMJUTDM-UHFFFAOYSA-N |
| XLogP | 38.39 |
| TPSA | 303.83 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 25 |
| Rotatable Bonds | 51 |
| Heavy Atoms | 197 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 3050.86 |
| LogP ≤ 5 | 38.39 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 25 |